XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Joint Venture (Tables)
12 Months Ended
Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Summary of Reconciliation Between the Carrying Value of Investment and Proportional Share of Underlying Equity in Net Assets of Joint Ventures

The following table shows the reconciliation between the carrying value of the Company's investment in the JV and its proportional share of the underlying equity in net assets of the JV (in thousands):

 

 

 

June 30,
2024

 

 

June 30,
2023

 

Carrying value of investment in joint venture

 

$

9,826

 

 

$

15,128

 

Deferred intra-entity profit margin

 

 

9,835

 

 

 

5,737

 

Equity method goodwill

 

 

(4,720

)

 

 

(4,720

)

Proportional share of equity investment in joint venture

 

$

14,941

 

 

$

16,145

 

Summary of Financial Information of Joint Ventures (Operations Data)

Summarized financial information of the JV is as follows (in thousands):

 

Statement of Operations Data:

 

Twelve Months Ended
March 31, 2024

 

 

Twelve Months Ended
March 31, 2023

 

 

Twelve Months Ended
March 31, 2022

 

Revenue

 

$

114,942

 

 

$

109,097

 

 

$

55,190

 

Gross profit

 

$

22,137

 

 

$

21,522

 

 

$

15,915

 

Net income

 

$

3,750

 

 

$

5,280

 

 

$

422

 

Net income attributable to the Company

 

$

1,838

 

 

$

2,572

 

 

$

241

 

Summary of Financial Information of Joint Ventures (Balance Sheet Data)

Summarized Balance Sheet Data:

 

As of
March 31, 2024

 

 

As of
March 31, 2023

 

Assets

 

 

 

 

 

 

Current assets

 

$

102,500

 

 

$

87,662

 

Non current assets

 

 

12,425

 

 

 

16,504

 

Total assets

 

$

114,925

 

 

$

104,166

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities

 

$

79,300

 

 

$

70,189

 

Non current liabilities

 

 

113

 

 

 

398

 

Stockholder's equity

 

 

35,512

 

 

 

33,579

 

Total liabilities and stockholders' equity

 

$

114,925

 

 

$

104,166

 

Schedule of Deferred Intra Entity Profit Margin from Sales to the Joint Ventures

The following table shows the activity of the Company’s deferred intra-entity profit margin from sales to the JV (in thousands):

 

 

 

Years Ended June 30,

 

 

 

2024

 

 

2023

 

 

2022

 

Deferred intra-entity profit margin recognized on sales to the JV

 

$

9,061

 

 

$

10,436

 

 

$

4,007

 

Deferred intra-entity profit margin on sales to the JV

 

 

(13,159

)

 

 

(10,718

)

 

 

(7,307

)

Net deferred profit margin on sales to the JV (1)

 

$

(4,098

)

 

$

(282

)

 

$

(3,300

)

 

(1)
Profit earned by the Company from the JV is eliminated through cost of goods sold until it is realized; such profits would generally be considered realized when the inventory has been sold through to third parties.